Most Anticipated Drug Launches of 2023

Letting new drugs into the market is never easy, so only a few entries get passed the strict FDA regulations annually.  Those that do pass, though, have the potential to enrich the current drug market and make it easier for both physicians and patients to get the most out of treatments.  Regarding the types of […]

Novel FDA Drug Approvals in 2022

Coming up with a new drug that can help save lives or at least alleviate the symptoms of patients worldwide is a noble pursuit with a tough road ahead.  Getting a drug approved is justifiably rigorous and arduous, as the lives of people taking the drugs can get significantly affected by them – for better […]

Sustainability in Pharma: How Does it Measure Up?

No expense is too high to test, develop, and distribute a drug thoroughly. After all, we are talking about the health and well-being of humans.  Despite the appearance of drugs as small, easy to mass produce, and relatively inexpensive, developing, testing, and making a drug takes a lot of time, resources, and energy.  As more […]

What is a CRO in Clinical Trials?

When it comes to coming up with a new drug, treatment, or way of handling any ailment or trauma, testing the waters first is essential for preventing the new drug from having exactly the opposite effect of the initially intended one.  Now, clinical trials often take a long time for well-justified reasons.  Rather than giving […]

Cardiovascular Outcomes Trials Answer Long-Asked Questions – But New Questions Arise

The recent American Diabetes Association’s 75th Scientific Sessions in Boston saw the release of data from the ELIXA cardiovascular outcomes trial (CVOT) for lixisenatide (Sanofi/Zealand Pharma’s Lyxumia), the first such trial completed for the GLP-1 receptor agonist drug class. However, it was the publication of the data from the CVOT for sitagliptin (Merck’s Januvia/Ono’s Glactiv), […]

FDA Advisory Panel Approves Novel Cholesterol-Lowering Drug

An advisory committee for the Food and Drug Administration has recommended the approval of a novel, injectable cholesterol-lowering drug called alirocumab, though many committee members have noted certain restrictions for its use and have requested further data on the drug’s ability to reduce the risk of heart problems. According to the Centers for Disease Control […]

FDA Advisory Panel Approves Flibanserin, Experimental ‘Viagra For Women’

Flibanserin is being hailed as “Viagra for women.” The experimental drug – designed for post-menopausal women with low sex drives – has now won approval from an advisory panel for the Food and Drug Administration (FDA). The FDA previously rejected the female libido pill twice since 2010 over concerns of side effects. In 2005, an […]

Insulin Produced in Constantine Available on Market in H1 of 2016

BOSTON (USA) – Saïdal Group Marketing Director Naili Saad-Eddine Yahia, said Saturday in Boston (USA) that the insulin produced in Constantine will be available on the national market in the first half of 2016. On the sidelines of the 75th Session of the American Diabetes Association, the same official said that Constantine insulin production plant […]

Asco 2015 Round-Up: Immunotherapy Continues to Come of Age

As you’ll have probably spotted by the array of cancer stories in the media over the last week, the world’s biggest annual cancer conference has just taken place. The annual American Society of Clinical Oncology (ASCO) meeting brings together over 30,000 oncology professionals from around the world to discuss research into new treatments, practices and […]

Virotherapy: Skin Cancer Successfully Treated With Herpes-Based Drug

Virotherapy’ uses modified herpes virus to attack melanoma cells and has potential to overcome cancer even when disease has spread throughout the body. Patients with aggressive skin cancer have been treated successfully using a drug based on the herpes virus, in a trial that could pave the way for a new generation of cancer treatments. […]

New Drug Combination Could Extend Life of Cystic Fibrosis Patients

An international research team has demonstrated that a combination of two different drugs targeting the most common genetic cause of cystic fibrosis helped to improve lung function and reduce the rate of pulmonary exacerbations. “These results represent a further major advance in finding treatments which correct the basic problem in cystic fibrosis and improve the […]

Fraunhofer ITEM: Successful Testing of New Drug for Allergic Asthma

A novel therapeutic principle is aimed at controlling the airway inflammation in allergic asthma, to mitigate the course of the disease. With its comprehensive expertise, Fraunhofer ITEM successfully performed toxicology testing of the novel DNAzyme-based drug developed by sterna biologicals GmbH & Co. KG and also part of the clinical trials. The results of the […]